This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by La Villa, G. Articles by Franchi, F. Search for Related Content PubMed PubMed Citation Articles by La Villa, G. Articles by Franchi, F. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

(Hypertension. 1995;26:628-633.)
© 1995 American Heart Association, Inc.

Articles

Acute Effects of Physiological Increments of Brain Natriuretic Peptide in Humans

Giorgio La Villa; Laura Stefani; Chiara Lazzeri; Claudia Zurli; Cristina Tosti Guerra; Giuseppe Barletta; Renzo Bandinelli; Gaetano Strazzulla; Franco Franchi

From the Cardiovascular Unit, Istituto di Medicina Interna (G.L.V., L.S., C.L., C.T.G., G.S., F.F.), Endocrinology Unit, Dipartimento di Fisiopatologia Clinica (C.Z.), and Cardiovascular Unit, Clinica Medica I (G.B.), University of Florence School of Medicine; and Laboratorio Centrale di ANALISI, Azienda Ospedaliera di Careggi (R.B.), Florence, Italy.

Abstract To investigate the effects of physiological increases in plasma brain natriuretic peptide concentration in humans, we studied six healthy volunteers who received incremental infusions (0.25 pmol/kg per minute in the first hour and 0.50 pmol/kg per minute in the second) of synthetic human brain natriuretic peptide-32 in a placebo-controlled, crossover study. Peptide plasma levels were 1.69±0.39 pmol/L at baseline and rose 1.5- and 3-fold with the lower and higher doses, respectively. These values were within the normal range and also comparable to those reported in patients with mild essential hypertension. The urinary excretion rate of cGMP also increased during brain natriuretic peptide infusion, indicating stimulation of natriuretic peptide receptors. Peptide administration induced a significant 1.7-fold increase in urinary sodium excretion without affecting renal plasma flow (para-aminohippurate clearance), glomerular filtration rate (creatinine clearance), and urine flow rate. Fractional proximal sodium reabsorption (lithium clearance method) was unchanged, and fractional distal sodium reabsorption significantly decreased. Brain natriuretic peptide caused no changes in arterial pressure, heart rate, hematocrit, and serum proteins, but it exerted an inhibitory effect on the renin-aldosterone axis, as indicated by the significant 50% or more decrease of plasma renin activity and urinary excretion rate of aldosterone. These results suggest that brain natriuretic peptide may be involved in the overall regulation of body fluid and cardiovascular homeostasis in humans, mainly through its natriuretic and endocrine effects.

Key Words: natriuretic peptides • kidney function tests • sodium • renin-angiotensin system • aldosterone

This article has been cited by other articles:

				K. van der Zander, A. J. H. M. Houben, L. Hofstra, A. A. Kroon, and P. W. de Leeuw Hemodynamic and renal effects of low-dose brain natriuretic peptide infusion in humans: a randomized, placebo-controlled crossover study Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1206 - H1212. [Abstract] [Full Text] [PDF]

				K. van der Zander, A. J.H.M. Houben, A. A. Kroon, T. K.A. Wierema, M. J.M.J. Fuss-Lejeune, D. Koster, and P. W. de Leeuw Does Brain Natriuretic Peptide Have a Direct Renal Effect in Human Hypertensives? Hypertension, January 1, 2003; 41(1): 119 - 123. [Abstract] [Full Text] [PDF]

				R. L. Woods and M. J. M. Jones Atrial, B-type, and C-type natriuretic peptides cause mesenteric vasoconstriction in conscious dogs Am J Physiol Regulatory Integrative Comp Physiol, May 1, 1999; 276(5): R1443 - R1452. [Abstract] [Full Text] [PDF]

				C. Zellner, A. A. Protter, E. Ko, M. R. Pothireddy, T. DeMarco, S. J. Hutchison, T. M. Chou, K. Chatterjee, and K. Sudhir Coronary vasodilator effects of BNP: mechanisms of action in coronary conductance and resistance arteries Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H1049 - H1057. [Abstract] [Full Text] [PDF]

				A. Luchner, T. L. Stevens, D. D. Borgeson, M. Redfield, C.-M. Wei, J. G. Porter, and J. C. Burnett Jr. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure Am J Physiol Heart Circ Physiol, May 1, 1998; 274(5): H1684 - H1689. [Abstract] [Full Text] [PDF]

				G. Barletta, C. Lazzeri, S. Vecchiarino, R. Del Bene, G. Messeri, A. Dello Sbarba, M. Mannelli, and G. La Villa Low-Dose C-Type Natriuretic Peptide Does Not Affect Cardiac and Renal Function in Humans Hypertension, March 1, 1998; 31(3): 802 - 808. [Abstract] [Full Text] [PDF]

				K. T. Jensen, J. Carstens, and E. B. Pedersen Effect of BNP on renal hemodynamics, tubular function and vasoactive hormones in humans Am J Physiol Renal Physiol, January 1, 1998; 274(1): F63 - F72. [Abstract] [Full Text] [PDF]

				J. G. Lainchbury, A. M. Richards, M. G. Nicholls, P. J. Hunt, H. Ikram, E. A. Espiner, T. G. Yandle, and E. Begg The Effects of Pathophysiological Increments in Brain Natriuretic Peptide in Left Ventricular Systolic Dysfunction Hypertension, September 1, 1997; 30(3): 398 - 404. [Abstract] [Full Text]